Clinical Trial Update: Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

View source ↗

Summary

A clinical trial assessing fracture risk in bone metastases derived from carcinoma is currently recruiting. The document provides an update on the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Snippet

Sponsor: Costantino Errani | Conditions: Bone Metastases | Status: RECRUITING